IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery

Androgen deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry

(2021) D.H. Kwon et al.   ANNALS OF ONCOLOGY

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

(2021) Joaquim Bellmunt et al.   LANCET ONCOLOGY

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

(2021) Thomas Powles et al.   NATURE MEDICINE

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

(2021) Thomas Powles et al.   NATURE

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

(2021) Dean F. Bajorin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

(2021) T. Powles et al.   ANNALS OF ONCOLOGY

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma

(2019) Emil Christensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

(2017) Arjun V Balar et al.   LANCET

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

(2017) Arjun V Balar et al.   LANCET ONCOLOGY

Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer

(2017) Dora Niedersüss-Beke et al.   ONCOLOGY

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer

(2014) Takuya Koie et al.   MEDICAL ONCOLOGY

Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience

(2010) Faysal A. Yafi et al.   BJU INTERNATIONAL